We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current EMBC market cap is 1.04B. The company's latest EPS is USD 1.3470 and P/E is 13.33.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Revenue | 281.9M | 277.3M | 287.2M | 272.5M | 286.1M |
| Operating Income | 25.8M | 45.5M | 39.2M | 55.9M | 26.2M |
| Net Income | 6M | 20.1M | 28.9M | 14.7M | 14.6M |
| Year End 30 September 2024 | 2022 | 2023 | 2024 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.13B | 1.12B | 1.12B |
| Operating Income | 368.5M | 221.5M | 166.8M |
| Net Income | 223.6M | 70.4M | 78.3M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Assets | 1.21B | 1.22B | 1.2B | 1.27B | 1.29B |
| Total Liabilities | 2.04B | 2.01B | 1.97B | 2.03B | 2.02B |
| Total Equity | -821.7M | -793.5M | -769.6M | -763.7M | -738.3M |
| Year End 30 September 2024 | 2022 | 2023 | 2024 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.09B | 1.21B | 1.29B |
| Total Liabilities | 1.98B | 2.04B | 2.02B |
| Total Equity | -891.4M | -821.7M | -738.3M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Operating | 67.7M | -13.1M | 11.2M | 9.1M | 35.7M |
| Investing | -26.5M | -2.7M | -6.1M | -15.8M | -15.8M |
| Financing | -48.7M | -13.5M | -25.3M | -36.8M | -73.4M |
| Year End 30 September 2024 | 2022 | 2023 | 2024 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Operating | 412.2M | 67.7M | 35.7M |
| Investing | -24M | -26.5M | -15.8M |
| Financing | -48M | -48.7M | -73.4M |
| Market Cap | 1.04B |
| Price to Earnings Ratio | 13.33 |
| Price to Sales Ratio | 0.93 |
| Price to Cash Ratio | 3.9 |
| Price to Book Ratio | -1.41 |
| Dividend Yield | 3.34% |
| Shares Outstanding | 58.13M |
| Average Volume (1 week) | 262.07k |
| Average Volume (1 Month) | 340.36k |
| 52 Week Change | 5.59% |
| 52 Week High | 21.48 |
| 52 Week Low | 9.925 |
| Spread (Intraday) | 7.15 (35.77%) |
| Company Name | Embecta Corporation |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.embecta.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
